Remedy’s Board of Directors is responsible for Remedy’s governance and the appropriate organization of its business operations.

The Board of Directors has approved a written Charter setting out its duties. Pursuant to the Charter, the Board of Directors duties include, for example, to approve Remedy’s strategy and to appoint the CEO.

Pursuant to Remedy’s Articles of Association, its Board of Directors shall comprise no less than three and no more than six ordinary members. One to six deputy members may also be elected to the Board of Directors. Board members’ term of office is until the conclusion of the first Annual General Meeting following their election. The Board of Directors elects a Chairman from among its members.

Remedy’s Board of Directors has not established any committees.

Board of Directors

Markus Mäki

Chairman of the Board of Directors since 1998
Chief Product Officer
A major shareholder, non-independent from the company and non-independent from major shareholders
Remedy shares owned: 3,197,000 (23.72%)

Markus Mäki (b. 1974) is one of Remedy’s original founders. He has been a member of Remedy’s Board of Directors since 1995.

Mäki is one of the pioneers of the Finnish video game industry with decades of experience including being one of the key people behind Futuremark Ltd. He has participated in every Remedy game project since the founding of the company, mainly in production and technology management roles.

Mäki holds an English bachelor’s degree in Computer Engineering from the Espoo-Vantaa Institute of Technology (currently Metropolia University of Applied Sciences).

Henri Österlund

Member of the Board of Directors since 2017
Independent from the company, but not from its major shareholders
Remedy shares owned: 46,139* (< 1%)

Henri Österlund (b. 1971) is the founder of Accendo Capital SICAV-RAIF. Previously, Österlund has served as a partner of Coventum Corporate Finance, partner of the Triton Private Equity investment fund in London, and as an Analyst at the Doughty Hanson Private Equity fund in Stockholm. He began his career at Landesbank Schleswig-Holstein in Kiel.

Österlund holds a master’s degree in economics from the Helsinki School of Economics (currently Aalto University).

*Henri Österlund’s direct Remedy shareholding. Henri Österlund is also the founder of Accendo Capital SICAV-RAIF. As per July 31, 2023 Accendo Capital SICAV-RAIF shareholding in Remedy was 2,063,162 shares.

Kaisa Salakka

Member of the Board of Directors since 2022
Independent from the company and its major shareholders
Remedy shares owned: 1,150 (< 1%)

Kaisa Salakka (b. 1979) has some ten years of experience of working in the games industry. For the past seven years, she has acted as a Product and Research Director at Unity Software Inc. where she lead new product development for game services and advertising. She has recently been appointed the head of Wolt’s consumer products business. She is also a member of the Board of Directors of Suomen Startup-yhteisö ry and Alma Media Corporation.

Salakka holds a Master’s degree in economics from the Helsinki School of Economics (Aalto University).

Sonja Ängeslevä

Member of the Board of Directors since 2022
Independent from the company and its major shareholders
Remedy shares owned: 1482 (< 1 %)

Sonja Ängeslevä (b. 1974) is the CEO and co-founder of Phantom Gamelabs, a company operating in the mobile games industry. Ängeslevä has extensive experience in mobile B2B and B2C product development. She has acted as Product Lead at Zynga for four years. Prior to joining Zynga, she served in product development leadership positions at Unity Technologies and the German gaming software company Scoreloop AG. Ängeslevä has actively developed the Finnish game industry ecosystem as the first President of IGDA Finland, Chairman of the Board of Neogames and founder of Women in Games Finland. She has received a lifetime award, amongst other awards, for her work for the industry.

Ängeslevä holds a Master’s degree in Digital Media from the University of Lapland.

Kai Tavakka

Member of the Board of Directors since 2024
Independent from the company, but not from its major shareholders
Remedy shares owned: 0*

Kai Tavakka (b. 1986) is the managing partner of Accendo Capital SICAV-RAIF. Tavakka has experience in active ownership, working together with boards, nomination committees, and management teams. He has previously worked at PCA Corporate Finance and Danske Bank. Tavakka is a member of the Board of Directors of Careium AB and SSH Comunications Security Oyj amongst others.

Tavakka holds a Master’s degree in Economics from Aalto University and is a CFA Charterholder from the CFA institute.

*Kai Tavakka’s direct Remedy shareholding. Kai Tavakka is also the managing partner of Accendo Capital SICAV-RAIF. As per December 31, 2023, Accendo Capital SICAV-RAIF shareholding in Remedy was 2,063,162 shares.

 

The information above reflects the situation as of April 12, 2024.